Molecular imaging and therapy: New paradigms for 21st century medicine

ACS Symposium Series

Volumn 923, Issue , 2006, Pages 295-311

  Lanza, G M ^a   Winter, P M ^a   Hughes, M S ^a   Caruthers, S D ^a,b   Marsh, J N ^a   Morawski, A M ^a   Schmieder, A H ^a   Scott, M J ^a   Fuhrhop, R W ^a   Zhang, H ^a   Hu, G ^a   Lacy, E K ^a   Allen, J S ^a   Wickline, S A ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36949034100     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: 10.1021/bk-2006-0923.ch021     Document Type: Conference Paper

References (25)

1. Weissleder R. Molecular imaging: Exploring the next frontier. Radiology 1999, 212, 609-614.
2. Lanza G.M., Wallace K., Scott M.J., Cacheris W., Abendschein D.R., Christy D., Sharkey A., Miller J.G., Gaffney P.J., Wickline S.A. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996, 94, 3334-3340.
3. Lanza G.M., Lorenz C., Fischer S., Scott M.J., Cacheris W., Kaufman R.J., Gaffney P.J., Wickline S.A. Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent. Acad Radiol. 1998, 5 (suppl. 1), s173-s176.
4. Lanza G.M., Yu X., Winter P.M., Abendschein D.R., Karukstis K.K., Scott M.J., Chinen L.K., Fuhrhop R.W., Scherrer D.E., Wickline S.A. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: Implications for rational therapy of restenosis. Circulation 2002, 106, 2842-2847.
5. Mattrey R.F. The potential role of perfluorochemicals (PFCs) in diagnostic imaging. Artif Cells. Blood Substit. Immobil. Biotechnol. 1994, 22, 295-313.
6. Mattrey R.F., Scheible F., Gosink B., Leopold G., Long D., Higgins C. Perfluoroctylbromide: A liver/spleen-specific and tumor-imaging ultrasound contrast material. Radiology 1982, 145, 759-762.
7. Hughes M.S., Marsh J.N., Hall C.S., Fuhrhop R.W., Scott M.J., Lanza G.M., Wickline S.A. Optimization of site-targeted perfluorocarbon nanoparticle contrast in whole blood for molecular imaging applications. J Acous. Soc Am. 2004, in press.
8. Lanza G.M., Abendschein D.R., Hall C.S., Marsh J.N., Scott M.J., Scherrer D, Wickline S.A. Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound. Invest Radiol. 2000, 35, 227-234.
9. Flacke S., Fischer S., Scott M.J., Fuhrhop R.W., Allen J.S., McLean M., Winter P.M., Sicard G., Gaffney P.J., Wickline S.A., Lanza G.M. A novel MRI contrast agent for molecular imaging of fibrin: Implications for detecting vulnerable plaques. Circulation 2001, 104, 1280-1285.
10. Winter P.M., Caruthers S.D., Kassner A., Harris T.D., Chinen L.K., Allen J.S., Lacy E.K., Zhang H., Robertson J.D., Wickline S.A., Lanza G.M. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(v)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res. 2003, 63, 5838-5843.
11. Winter P.M., Morawski A.M., Caruthers S.D., Fuhrhop R.W., Zhang H., Williams T.A., Allen J.S., Lacy E.K., Robertson J.D., Lanza G.M., Wickline S.A. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003, 108, 2270-2274.
12. Lanza G.M., Trousil R., Wallace K., Rose J.H., Hall C.S., Scott M.J., Miller J.G., Eisenberg P., Gaffney P.J., Wickline S.A. In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J Acoust Soc Am. 1998, 104, 3665-3672.
13. Hall C.S., Lanza G.M., Rose J.H., Kaufman R.J., Fuhrhop R.W., Handley S.H., Waters K.R., Miller J.G., Wickline S.A. Experimental Determination of Phase Velocity of Perfluorocarbons: Applications to Targeted Contrast Agents. IEEE Trans Ultrason Ferroelec Freq Contr. 2000, 47, 75-84.
14. Marsh J.N., Hall C.S., Scott M.J., Fuhrhop R.W., Gaffney P.J., Wickline S.A., Lanza G.M. Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model. IEEE Trans Ultrason Ferroelectr Freq Control. 2002, 49, 29-38.
15. Hall C.S., Marsh J.N., Scott M.J., Gaffney P.J., Wickline S.A., Lanza G.M. Temperature dependence of ultrasonic enhancement with a site-targeted contrast agent. JAcous. Soc AM. 2001, 110, 1677-1684.
16. Gupta H., Weissleder R. Targeted contrast agents in MR imaging. Magn Reson Imag Clinics N Am. 1996, 4, 171-84.
17. Weissleder R., Stark D.D., Compton C.C., Wittenberg J., Ferrucci J.T. Ferrite-enhanced MR imaging of hepatic lymphoma: An experimental study in rats. AJR. 1987, 149, 1161-1165.
18. Weissleder R., Elizondo G., Wittenberg J., Rabito C.A., Bengele H.H., Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990, 75, 489-493.
19. Moore A., Weissleder R., Bogdanov A., Jr. Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J Magn Reson Imaging 1997, 7, 1140-1145.
20. Sipkins D.A., Cheresh D.A., Kazemi M.R., Nevin L.M., Bednarski M.D., Li K.C. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med. 1998, 4, 623-626.
21. Anderson S.A., Rader R.K., Westlin W.F., Null C., Jackson D., Lanza G.M., Wickline S.A., Kotyk J.J. Magnetic resonance contrast enhancement of neo vasculature with alpha(v)beta(3)-targeted nanoparticles. Magn Reson Med. 2000, 44, 433-439.
22. Schmieder A.H., Winter P.M., Caruthers S.D., Harris T.D., Chinen L., Williams T., Watkins M., Allen J.S., Wickline S.A., Lanza G.M. Molecular imaging of angiogenesis in human melanoma xenografts in nude mice by MRI (1.5T) with avB3-targeted nanoparticles. Mol. Imaging 2002, 1, 190.
23. Winter P.M., Caruthers S.D., Yu X., Song S.K., Chen J., Miller B., Bulte J.W., Robertson J.D., Gaffney P.J., Wickline S.A., Lanza G.M. Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med. 2003, 50, 411-416.
24. Moulton K.S., Heller E., Konerding M.A., Flynn E., Palinski W., Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimai neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999, 99, 1653-1655.
25. Morawski A.M., Winter P.M., Crowder K.C., Caruthers S.D., Fuhrhop R.W., Scott M.J., Robertson J.D., Abendschein D.R., Lanza G.M., Wickline S.A. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med. 2004, 51, 480-486.